Stay updated on STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.

Latest updates to the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedVersion bumped from v3.0.1 to v3.0.2, signaling a new release. The 'Back to Top' control was removed, which is a UI change and does not affect core content.SummaryDifference0.2%
- Check9 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%
- Check16 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with a list of relevant publications from PubMed related to ovarian cancer. Additionally, several specific cancer types and drug categories have been removed.SummaryDifference9%
- Check23 days agoChange DetectedThe page has been updated with new dates for events, specifically adding '2025-06-01', '2025-08-18', and '2025-08-22', while removing previous dates including '2024-11-07' and '2024-11-06'. Additionally, significant contact information for multiple study contacts and principal investigators has been removed.SummaryDifference5%
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.